"Atacand Plus" monotherapy effective for new hypertensive patients.

A study for 5,543 patients with high blood pressure in 5 major cities including Seoul, Busan, Daegu, Daejeon and Guangju who visited to private clinics reported that Atacand Plus, a combination anti-hypertension drug of an angiotensin receptor blocker and diuretics, showed an excellent hypotensive effect by 30/16mmHg down.

The study was based on "7th JNC report" of the U. S. NIH, recommend...